DEA failure to punish opioid distributor fuels revolving door questionThe delay raised concerns about how the revolving door between government and industry may be impacting the DEA’s mission to police drug companies.By Joshua Goodman10 days ago
Trump: Drug czar nominee pulls his name from considerationRep. Tom Marino, President Donald Trump’s nominee to be the nation’s drug czar, has withdrawn from consideration following reports that he played a key role in weakening the federal government’s authority to stop companies from distributing opioids.6 years ago